Drug Database
Back to search

Poland· PL-100411740

Dexibuprofen Strides

A dexibuprofen product containing dexibuprofenum, registered in Poland by Strides Pharma (Cypr) Limited. The same ATC class is registered in 10 of our 19 countries.

ATC M01AE14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDexibuprofen StridesATCM01AE14REGISTER NO.PL-100411740PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexibuprofenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dexibuprofen is registered in 10 of 19 countries.

Countries holding a registration under ATC M01AE14 (dexibuprofen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search dexibuprofen products by name

Dexibuprofen · ATC M01AE14

10 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Italyprice
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexibuprofen costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.55 in Italy to $1.51 in Switzerland — a ×2.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dexibuprofen · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.51
  • IT Italy$0.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Dexibuprofenum
Manufacturer
Strides Pharma (Cypr) Limited
Country
Poland (PL)
ATC code
M01AE14
ATC class
Dexibuprofen
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991571146
  • gtin
    05909991571153
  • gtin
    05909991571160
  • gtin
    05909991571177
  • gtin
    05909991571184
  • gtin
    05909991571191

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for dexibuprofen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dexibuprofen against other medicinesHow interaction checks work

Dexibuprofen · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dexibuprofen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexibuprofen products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Atriscal, Dexibuprofen Fairmed
  • Czechia · Dexibuprofen Strides, Ibolex
  • Germany · Deltaran, Dexibu
  • Denmark · Seractiv
  • Spain · Atriscal, Dexibuprofeno Strides
  • United Kingdom (Northern Ireland) · Dexibuprofen Strides Pharma Uk
  • Greece · Seractil
  • Hungary · Dexibuprofen Gebro, Dexibuprofen Strides
  • Italy · Fenextra, Seractil
  • Portugal · Seractil
  • Romania · Seractil
  • Sweden · Dexibuprofen Strides, Tradil
  • Slovakia · Dexibuprofén Strides, Ibolex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/196fd04a-832e-4751-aa2e-ff28727ce7f7
GET /v1/drugs/196fd04a-832e-4751-aa2e-ff28727ce7f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909991571146 ¦ Rp ¦ 161527\n4 tabl.\n05909991571153 ¦ Rp ¦ 161528\n10 tabl.\n05909991571160 ¦ Rp ¦ 161529\n20 tabl.\n05909991571177 ¦ Rp ¦ 161530\n30 tabl.\n05909991571184 ¦ Rp ¦ 161531\n50 tabl.\n05909991571191 ¦ Rp ¦ 161532\n60 tabl.",
  "substance": "Dexibuprofenum 400 mg",
  "common_name": "Dexibuprofenum",
  "pl_product_id": "100411740",
  "pozwolenie_nr": "28999",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about dexibuprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console